tradingkey.logo
tradingkey.logo
Search

Disc Medicine Inc

IRON
Add to Watchlist
77.000USD
-2.210-2.79%
Close 07-31 16:00ETQuotes delayed by 15 min
2.96BMarket Cap
LossP/E TTM

IRON Income Statement

You can find the annual or quarterly income statement of Disc Medicine Inc here for insights into the performance and operational efficiency of Disc Medicine Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Operating expenses
5.97%65.08M
74.04%69.52M
93.84%66.97M
106.04%67.70M
99.05%61.41M
26.97%39.95M
16.28%34.55M
73.31%32.86M
78.05%30.85M
25.22%31.46M
39.33%29.71M
407.31%18.96M
139.54%17.33M
86.43%25.13M
20.21%21.33M
-79.75%3.74M
-55.67%7.23M
-18.27%13.48M
5594.13%17.74M
3594.35%18.45M
--16.32M
--16.49M
--311.58K
--499.41K
R&D expenses
1.33%46.93M
65.34%45.90M
86.41%46.22M
103.91%50.33M
97.23%46.32M
17.12%27.76M
9.89%24.80M
71.20%24.68M
94.09%23.48M
17.46%23.70M
9.46%22.57M
3192.01%14.42M
368.99%12.10M
129.21%20.18M
63.17%20.61M
-96.74%438.00K
-76.20%2.58M
-25.30%8.80M
--12.63M
--13.46M
--10.84M
--11.79M
----
----
Depreciation, depletion, and amortization
5.88%90.00K
345.00%89.00K
888.89%89.00K
690.91%87.00K
-22.73%85.00K
-23.08%20.00K
-64.00%9.00K
-56.00%11.00K
340.00%110.00K
4.00%26.00K
--25.00K
--25.00K
--25.00K
--25.00K
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--46.00K
--58.00K
--62.00K
--65.00K
----
----
Other operating expenses
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---3.04K
---1.49K
Operating profit
-5.97%-65.08M
-74.04%-69.52M
-93.84%-66.97M
-106.04%-67.70M
-99.05%-61.41M
-26.97%-39.95M
-16.28%-34.55M
-73.31%-32.86M
-78.05%-30.85M
-25.22%-31.46M
-39.33%-29.71M
-407.31%-18.96M
-139.54%-17.33M
-86.43%-25.13M
-20.21%-21.33M
79.75%-3.74M
55.67%-7.23M
18.27%-13.48M
-5594.13%-17.74M
-3594.35%-18.45M
---16.32M
---16.49M
---311.58K
---499.41K
Net non-operating interest income (expenses)
Non-operating interest income
-7.44%6.53M
0.19%6.89M
26.96%7.41M
0.79%6.41M
54.32%7.06M
52.25%6.88M
24.82%5.84M
31.36%6.36M
57.15%4.57M
90.92%4.52M
2159.42%4.68M
870.54%4.84M
1853.02%2.91M
26200.00%2.37M
5075.00%207.00K
9880.00%499.00K
2880.00%149.00K
800.00%9.00K
--4.00K
--5.00K
--5.00K
--1.00K
----
----
Non-operating interest expense
-0.22%908.00K
-5.91%844.00K
54.37%883.00K
--917.00K
--910.00K
--897.00K
--572.00K
----
----
----
----
----
----
----
----
-60.58%41.00K
-60.33%48.00K
-96.43%66.00K
--85.00K
--104.00K
--121.00K
--1.85M
----
----
Special income (expenses)
----
----
----
----
----
----
----
--0.00
100.00%0.00
----
2559.02%1.50M
--0.00
---1.50M
100.00%0.00
---61.00K
--0.00
--0.00
-139.10%-1.70M
--0.00
--0.00
--0.00
---711.00K
----
----
Other non-operating income (expenses)
-117.65%-12.00K
833.33%22.00K
-166.67%-2.00K
-300.00%-18.00K
623.08%68.00K
-200.00%-3.00K
130.00%3.00K
-30.77%9.00K
-160.00%-13.00K
---1.00K
79.17%-10.00K
550.00%13.00K
-111.63%-5.00K
----
---48.00K
200.00%2.00K
490.91%43.00K
--3.00K
--0.00
---2.00K
---11.00K
----
----
----
Income before tax
-7.73%-59.46M
-86.81%-63.45M
-106.42%-60.44M
-134.92%-62.22M
-109.93%-55.20M
-26.06%-33.97M
-24.35%-29.28M
-87.81%-26.48M
-65.12%-26.29M
-18.39%-26.94M
-10.92%-23.55M
-330.33%-14.10M
-124.58%-15.92M
-49.42%-22.76M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
20.04%-15.23M
-5620.13%-17.82M
-3614.58%-18.55M
---16.45M
---19.05M
---311.58K
---499.41K
Income tax
32.69%69.00K
-57.14%51.00K
-50.00%88.00K
-10.53%102.00K
-13.33%52.00K
2280.00%119.00K
450.00%176.00K
470.00%114.00K
150.00%60.00K
-78.26%5.00K
--32.00K
--20.00K
--24.00K
--23.00K
----
----
----
----
----
----
----
----
--0.00
----
Income after tax
-7.76%-59.53M
-86.31%-63.50M
-105.49%-60.53M
-134.30%-62.32M
-109.65%-55.25M
-26.48%-34.09M
-24.93%-29.46M
-88.35%-26.60M
-65.25%-26.35M
-18.30%-26.95M
-11.07%-23.58M
-330.94%-14.12M
-124.92%-15.95M
-49.57%-22.78M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
20.04%-15.23M
-5620.13%-17.82M
-3614.58%-18.55M
---16.45M
---19.05M
---311.58K
---499.41K
Net income from continuous operations
-7.76%-59.53M
-86.31%-63.50M
-105.49%-60.53M
-134.30%-62.32M
-109.65%-55.25M
-26.48%-34.09M
-24.93%-29.46M
-88.35%-26.60M
-65.25%-26.35M
-18.30%-26.95M
-11.07%-23.58M
-330.94%-14.12M
-124.92%-15.95M
-49.57%-22.78M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
20.04%-15.23M
-5620.13%-17.82M
-3614.58%-18.55M
---16.45M
---19.05M
---311.58K
---499.41K
Net income attributable to controlling interests
-7.76%-59.53M
-86.31%-63.50M
-105.49%-60.53M
-134.30%-62.32M
-109.65%-55.25M
-26.48%-34.09M
-24.93%-29.46M
-88.35%-26.60M
-65.25%-26.35M
-18.30%-26.95M
-11.07%-23.58M
-330.94%-14.12M
-124.92%-15.95M
-49.57%-22.78M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
20.04%-15.23M
-5620.13%-17.82M
-3614.58%-18.55M
---16.45M
---19.05M
---311.58K
---499.41K
Net income attributable to common shareholders
-7.76%-59.53M
-86.31%-63.50M
-105.49%-60.53M
-134.30%-62.32M
-109.65%-55.25M
-26.48%-34.09M
-24.93%-29.46M
-88.35%-26.60M
-65.25%-26.35M
-18.30%-26.95M
-11.07%-23.58M
-330.94%-14.12M
-124.92%-15.95M
-49.57%-22.78M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
20.04%-15.23M
-5620.13%-17.82M
-3614.58%-18.55M
---16.45M
---19.05M
---311.58K
---499.41K
Basic earnings per share
2.44%-1.54
-61.30%-1.65
-63.78%-1.61
-99.38%-1.77
-53.53%-1.58
5.84%-1.02
-1.82%-0.98
-53.00%-0.89
-38.42%-1.03
9.62%-1.09
20.93%-0.96
23.32%-0.58
54.74%-0.74
65.90%-1.20
70.46%-1.22
82.41%-0.76
57.08%-1.64
40.74%-3.52
-1851.28%-4.13
-1239.04%-4.30
---3.82
---5.95
---0.21
---0.32
Diluted earnings per share
2.44%-1.54
-61.30%-1.65
-63.78%-1.61
-99.38%-1.77
-53.53%-1.58
5.84%-1.02
-1.82%-0.98
-53.00%-0.89
-38.42%-1.03
9.62%-1.09
20.93%-0.96
23.32%-0.58
54.74%-0.74
65.90%-1.20
70.46%-1.22
82.41%-0.76
57.08%-1.64
40.74%-3.52
-1851.28%-4.13
-1239.04%-4.30
---3.82
---5.95
---0.21
---0.32
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Disc Medicine Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing IRON stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Disc Medicine Inc's net income for the year?

Disc Medicine Inc posted -212.18M in net income for fiscal year 2025.

How much net income did Disc Medicine Inc post in the last quarter?

Disc Medicine Inc reported -59.53M in net income for the latest quarter。

What was Disc Medicine Inc's annual operating profit?

Disc Medicine Inc's operating income was -236.02M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.